{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-061174","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2026-09-09T21:21:52+00:00","discovered_at":"2026-09-09T21:24:00.476206+00:00","generated_at":"2026-09-09T21:24:04.040762+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioLife HSR waiting period expires for Repligen acquisition; vote set for Oct 5","bullets":["HSR waiting period expired Sept 3, 2026, clearing antitrust condition for Repligen merger.","Deal consideration: $11.25 cash + 0.1442 Repligen shares per BioLife share.","Special stockholder meeting to vote on merger scheduled Oct 5, 2026 at 9:00 a.m. ET.","Merger still subject to other closing conditions, including BioLife stockholder approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-061174","json":"https://secwatch.observer/filing/0001628280-26-061174.json","markdown":"https://secwatch.observer/filing/0001628280-26-061174.md","text":"https://secwatch.observer/filing/0001628280-26-061174.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000162828026061174/0001628280-26-061174-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000162828026061174/blfs-20260903.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-09T21:24:04.040762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}